A novel role for receptor-associated protein in somatostatin modulation: Implications for Alzheimer's disease

Neuroscience

Volumn 88, Issue 3, 1999, Pages 687-700

  Van Uden, E ^a   Veinbergs, I ^a   Mallory, M ^a   Orlando, R ^b   Masliah, E ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

amyloid precursor protein; Alzheimer's disease; Apolipoprotein E; Low density lipoprotein receptor related protein; Receptor associated protein; Somatostatin

Indexed keywords

LOW DENSITY LIPOPROTEIN RECEPTOR; RECEPTOR PROTEIN; SOMATOSTATIN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; HIPPOCAMPUS; HORMONAL REGULATION; IMMUNOCYTOCHEMISTRY; IMMUNOREACTIVITY; IN SITU HYBRIDIZATION; KNOCKOUT MOUSE; LASER MICROSCOPY; MOUSE; NEOCORTEX; NERVE CELL DIFFERENTIATION; NERVE FUNCTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TISSUE DISTRIBUTION;

ALZHEIMER DISEASE; ANIMALS; BRAIN; CARRIER PROTEINS; COGNITION DISORDERS; GLYCOPROTEINS; HUMANS; LDL-RECEPTOR RELATED PROTEIN-ASSOCIATED PROTEIN; MAZE LEARNING; MICE; MICE, KNOCKOUT; MOLECULAR CHAPERONES; SOMATOSTATIN;

EID: 0032890435     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00272-3     Document Type: Article

References (50)

1. Anderson K. D., Alderson R. F., Altar C. A., DiStefano P. S., Corcoran T. L., Lindsay R. M. and Wiegand S. J. (1995) Differential distribution of exogenous BDNF, NGF, and NT-3 in the brain corresponds to the relative abundance and distribution of high-affinity and low-affinity neurotrophin receptors. J. comp. Neurol. 357, 296-317.
2. Aoyagi T., Wada T., Kojima F., Nagai M., Harada S., Takeuchi T., Isse K., Ogura M., Hamamoto M., Tanaka K. and Nagao T. (1992) Deficiency of fibrinolytic enzyme activities in the serum of patients with Alzheimer-type dementia. Experientia 48, 656-659.
3. Brownstein M., Arimura A., Sato H., Schally A. V. and Kizer J. S. (1975) The regional distribution of somatostatin in the rat brain. Endocrinology 96, 1456-1461.
4. Bu G., Geuze H. J., Strous G. J. and Schwartz A. L. (1995) 39-kDa receptor-associated protein is an ER resident protein and molecular chaperone for LDL receptor-related protein. Eur. molec. Biol. Org. J. 14, 2269-2280.
5. Bu G., Maksymovitch E. A., Geuze H. and Schwartz A. L. (1994) Subcellular localization and endocytic function of low density lipoprotein receptor-related protein in human glioblastoma cells. J. biol. Chem. 269, 29,874-29,882.
6. Carnahan J. and Nawa H. (1995) Regulation of neuropeptide expression in the brain by neurotrophins. Potential role in vivo. Molec. Neurobiol. 10, 135-149.
7. Croll S. D., Wiegand S. J., Anderson K. D., Lindsay R. M. and Nawa H. (1994) Regulation of neuropeptides in adult rat forebrain by the neurotrophins BDNF and NGF. Eur. J. Neurosci. 6, 1343-1353.
8. Dournaud P., Cervers-Pierot P., Hirsch E., Javoy-Agid F., Kordon C., Agid Y. and Epelbaum J. (1994) Somatostatin messenger RNA-containing neurons in Alzheimer's disease: an in situ hybridization study in hippocampus, parahippocampal cortex and frontal cortex. Neuroscience 61, 755-764.
9. Fox L., Mallory M., Achim C. and Masliah E. (1997) Neurodegeneration of somatostatin-immunoreactive neurons in HIV encephalitis. J. Neuropath. exp. Neurol. 56, 360-368.
10. Furukawa K., Sopher B. L., Rydel R. E., Begley J. G., Pham D. G., Martin G. M., Fox M. and Mattson M. P. (1996) Increased activity regulating and neuroprotective efficacy of α-secretase-derived secreted amyloid precursor protein conferred by a C-terminal heparin-binding domain. J. Neurochem. 67, 1882-1892.
11. Gabriel S. M., Bierer L. M., Harotunian V., Purohit D. P., Perl D. P. and Davis K. L. (1993) Widespread deficits in somatostatin but not neuropeptide Y concentrations in Alzheimer's disease cerebral cortex. Neurosci. Lett. 155, 116-120.
12. Gliemann J., Nykjaer A., Petersen C. M., Jorgensen K. E., Nielsen M., Andreasen P. A., Christensen E. I., Lookene A., Olivecrona G. and Moestrup S. K. (1994) The multiligand alpha 2-macroglobulin receptor-low density lipoprotein receptor-related protein (alpha 2MR/LRP). Binding and endocytosis of fluid phase and membrane-associated ligands. Ann. N. Y. Acad. Sci. 737, 20-38.
13. Herz J., Goldstein J. L., Strickland D. K., Ho Y. K. and Brown M. S. (1991) 39-kDa protein modulates binding of ligands to low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. J. biol. Chem. 266, 21,232-21,238.
14. Holtzman D. M., Pitas R. E., Kilbridge J., Nathan B., Mahley R. W., Bu G. and Schwartz A. L. (1995) Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line. Proc. natn. Acad. Sci. U.S.A. 92, 9480-9484.
15. Iwai A., Masliah E., Yoshimoto M., De Silva R., Ge N., Kittel A. and Saitoh T. (1994) The precursor protein of non-Aβ component of Alzheimer's disease amyloid (NACP) is a presynaptic protein of the central nervous system. Neuron 14, 467-475.
16. Kang D. E., Saitoh T., Chen X., Xia Y., Masliah E., Hansen L. A., Thomas R. G., Thal L. J. and Katzman R. (1997) Genetic association of the low density lipoprotein receptor related protein gene (LRP), an apoE receptor, with late-onset Alzheimer's disease. Neurology 49, 56-61.
17. Knauer M. F., Orlando R. A. and Glabe C. G. (1996) Cell surface APP751 forms complexes with protease nexin 2 ligands and is internalized via the low density lipoprotein receptor-related protein (LRP). Brain Res. 740, 6-14.
18. Koo P. H., Liebl D. J., Qiu W. S., Hu Y. Q. and Dluzen D. E. (1994) Monoamine-activated alpha 2-macroglobulin inhibits neurite outgrowth, survival, choline acetyltransferase, and dopamine concentration of neurons by blocking neurotrophin-receptor (trk) phosphorylation and signal transduction. Ann. N. Y. Acad. Sci. 737, 460-464.
19. Koo P. H. and Qiu W. S. (1994) Monoamine-activated alpha 2-macroglobulin binds trk receptor and inhibits nerve growth factor-stimulated trk phosphorylation and signal transduction. J. biol. Chem. 269, 5369-5376.
20. Kounnas M. Z., Moir R. D., Rebeck G. W., Bush A. I., Argaves W. S., Tanzi R. E., Hyman B. T. and Strickland D. K. (1995) LDL receptor-related protein, a multifunctional apoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation. Cell 82, 331-340.
21. Lendon C. L., Talbot C. J., Craddock N. J., Han S. W., Wragg M., Morris J. C. and Goate A. M. (1997) Genetic association studies between dementia of the Alzheimer's type and three receptors for apolipoprotein E in a Caucasian population. Neurosci. Lett. 222, 187-190.
22. Licastro F., Morini M. C., Polazzi E. and Davis L. J. (1995) Increased serum α1-antichymotripsin in patients with probable Alzheimer's disease: an acute phase reactant without the peripheral acute phase response. J. Neuroimmun. 57, 71-75.
23. Lorent K., Overbergh L., Moechars D., de Strooper B., Van Leuven F. and van den Berghe H. (1995) Expression in mouse embryos and in adult mouse brain of three members of the amyloid precursor protein family, of the alpha-2-macroglobulin receptor/low density lipoprotein receptor-related protein and of its ligands apolipoprotein E, lipoprotein lipase, alpha-2-macroglobulin and the 40,000 molecular weight receptor-associated protein. Neuroscience 65, 1009-1025.
24. Mahley R. W. (1988) Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 240, 622-630.
25. Masliah E., Mallory M., Ge N., Alford M., Veinbergs I. and Roses A. D. (1995) Neurodegeneration in the CNS of apoE-deficient mice. Expl Neurol. 136, 107-122.
26. Masliah E., Samuel W., Veinbergs I., Mallory M., Mante M. and Saitoh T. (1997) Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE. Brain Res. 751, 307-314.
27. Matsuoka N., Maeda N., Yamaguchi I. and Satoh M. (1994) Possible involvement of brain somatostatin in the memory formation of rats and the cognitive enhancing action of FR121196 in passive avoidance task. Brain Res. 642, 11-19.
28. Matsuoka N., Yamazaki M. and Yamaguchi I. (1995) Changes in brain somatostatin in memory-deficient rats: comparison with cholinergic markers. Neuroscience 66, 617-626.
29. Mattson M. P., Cheng B., Culwell A. R., Esch F. S., Lieberburg I. and Rydel R. E. (1993) Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein. Neuron 10, 243-254.
30. Molchan S. E., Hill J. L., Martinez R. A., Lawlor B. A., Mellow A. M., Rubinow D. R., Bissette G., Nemeroff C. B. and Sunderland T. (1993) CSF somatostatin in Alzheimer's disease and major depression: relationship to hypothalamic-pituitary-adrenal axis and clinical measures. Psychoneuroendocrinology 18, 509-519.
31. Montkowski A., Poettig M., Mederer A. and Holsboer F. (1997) Behavioural performance in three substrains of mouse strain 129. Brain Res. 762, 12-18.
32. Mucke L., Abraham C. R. and Masliah E. (1996) Neurotrophic and neuroprotective effects of hAPP in transgenic mice. Ann. N. Y. Acad Sci. 777, 82-88.
33. Mucke L., Abraham C. R., Ruppe M. D., Rockenstein E. M., Toggas S. M., Alford M. and Masliah E. (1995) Protection against HIV-1 gp120-induced brain damage by neuronal overexpression of human amyloid precursor protein (hAPP). J. exp. Med. 181, 1551-1556.
34. Nathan B. P., Bellosta S., Sanan D. A., Weisgraber K. H., Mahley R. W. and Pitas R. E. (1994) Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264, 850-852.
35. Nawa H., Bessho Y., Carnahan J., Nakanishi S. and Mizuno K. (1993) Regulation of neuropeptide expression in cultured cerebral cortical neurons by brain-derived neurotrophic factor. J. Neurochem. 60, 772-775.
36. Nawa H., Pelleymounter M. A. and Carnahan J. (1994) Intraventricular administration of BDNF increases neuropeptide expression in newborn rat brain. J. Neurosci. 14, 3751-3765.
37. Orlando R. A. and Farquhar M. G. (1993) Identification of a cell line that expresses a cell surface and soluble form of the gp330/receptor-associated protein (RAP) Heymann nephritis antigenic complex. Proc. natn. Acad. Sci. U.S.A. 90, 4082-4086.
38. Poirier J., Minnich A. and Davignon J. (1995) Apolipoprotein E, synaptic plasticity and Alzheimer's disease. Ann. Med. 27, 663.
39. Poller W., Willnow T. E., Hilpert J. and Herz J. (1995) Differential recognition of α1-antitrypsin-elastase and α1-antichymotrypsin-cathepsin G complexes by the low density lipoprotein receptor-related protein. J. biol. Chem. 270, 2841-2845.
40. Rebeck G. W., Harr S. D., Strickland D. K. and Hyman B. T. (1995) Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann. Neurol. 37, 211-217.
41. Saunders A. M., Strittmatter W. J., Schmechel D., St. George-Hyslop P. H., Pericak-Vance M. A., Joo S. H., Rosi B. L., Gusella J. F., Crapper-MacLachlan D. R., Alberts M. J., Hulette C., Crain B., Goldgaber D. and Roses A. D. (1993) Association of apolipoprotein E allele E4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467-1472.
42. Selkoe D. J. (1994) Normal and abnormal biology of the beta-amyloid precursor protein. A. Rev. Neurosci. 17, 489-517.
43. Strickland D. K., Kounnas M. Z. and Argraves W. S. (1995) LDL receptor-related protein: a multiligand receptor for lipoprotein and proteinase catabolism. Fedn Proc. Fedn Am. Socs exp. Biol. 9, 890-898.
44. Tanzi R. E., Wenniger J. J. and Hyman B. T. (1993) Cellular specificity and regional distribution of amyloid beta protein precursor alternative transcripts are unaltered in Alzheimer hippocampal formation. Brain Res. molec. Brain Res. 18, 246-252.
45. Vallejo M., Miller C. P., Bekman W. and Habener J. F. (1995) Repression of somatostatin gene transcription mediated by two promoter silencer elements. Molec. cell. Endocr. 113, 61-72.
46. Wavrant-DeVrieze F., Perez-Tur J., Lambert J. C., Frigard B., Pasquier F., Delacourte A., Amouyel P., Hardy J. and Chartier-Harlin M. C. (1997) Association between the low density lipoprotein receptor-protein (LRP) and Alzheimer's disease. Neurosci. Lett. 227, 68-70.
47. Williams S. E., Ashcom J. D., Argraves W. S. and Strickland D. K. (1992) A novel mechanism for controlling the activity of alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein. J. biol. Chem. 267, 9035-9040.
48. Willnow T. E., Armstrong S. A., Hammer R. E. and Herz J. (1995) Functional expression of low density lipoprotein receptor-related protein is controlled by receptor-associated protein in vivo. Proc. natn. Acad. Sci. U.S.A. 92, 4537-4541.
49. Wolf B. B. and Gonias S. L. (1994) Neurotrophin binding to human alpha 2-macroglobulin under apparent equilibrium conditions. Biochemistry 33, 11,270-11,277.
50. Zheng G., Bachinsky D. R., Stamenkovic I., Strickland D. K., Brown D., Andres G. and McCluskey R. T. (1994) Organ distribution in rats of two members of the low-density lipoprotein receptor gene family, gp330 and LRP/alpha 2MR, and the receptor-associated protein (RAP). J. Histochem. Cytochem. 42, 531-542.